SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Aly M) "

Sökning: WFRF:(Aly M)

  • Resultat 151-160 av 193
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
151.
  •  
152.
  •  
153.
  •  
154.
  •  
155.
  • Nordstrom, T, et al. (författare)
  • Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI
  • 2019
  • Ingår i: BMJ open. - : BMJ. - 2044-6055. ; 9:6, s. e027816-
  • Tidskriftsartikel (refereegranskat)abstract
    • Prostate cancer is a leading cause of cancer death among men in the Western world. Early detection of prostate cancer has been shown to decrease mortality, but has limitations with low specificity leading to unnecessary biopsies and overdiagnosis of low-risk cancers. The STHLM3 trial has paved way for improved specificity in early detection of prostate cancer using the blood-based STHLM3 test for identifying men at increased risk of harbouring significant prostate cancer. Targeted prostate biopsies based on MRI images have shown non-inferior sensitivity to detect significant prostate cancer and decrease the number of biopsies and non-significant cancers among men referred for prostate biopsy in clinical practice. The strategy of the STHLM3-MRI project is to study an improved diagnostic pathway including an improved blood-based test for identification of men with increased risk of prostate cancer and use of MRI to select men for diagnostic workup with targeted prostate biopsies.MethodsThis study compares prostate cancer detection using prostate-specific antigen (PSA) and systematic biopsies to the improved pathway for prostate cancer detection using the STHLM3 test and targeted biopsies in a screening context. The study will recruit 10 000 participants during 1 June 2018 to 1 June 2020 combining a paired and randomised design. Participants are grouped by PSA and Stockholm3 test level. Men with Stockholm3 ≥11% or PSA ≥3 ng/mL are randomised to systematic or MRI-targeted biopsies. This protocol follows SPIRIT guidelines. Endpoints include the number of detected prostate cancers, number of performed biopsy procedures and number of performed MRIs. Additional aims include to assess the health economic consequences and development of automated image-analysis.Ethics and disseminationThe study is approved by the regional ethical review board in Stockholm (2017-1280/31). The study findings will be published in peer-review journals. Findings will also be disseminated by conference/departmental presentations and by media.Trial registration numberNCT03377881; Pre-results.
  •  
156.
  •  
157.
  •  
158.
  •  
159.
  • Slieker, Roderick C, et al. (författare)
  • Identification of biomarkers for glycaemic deterioration in type 2 diabetes
  • 2023
  • Ingår i: Nature Communications. - 2041-1723. ; 14, s. 1-18
  • Tidskriftsartikel (refereegranskat)abstract
    • We identify biomarkers for disease progression in three type 2 diabetes cohorts encompassing 2,973 individuals across three molecular classes, metabolites, lipids and proteins. Homocitrulline, isoleucine and 2-aminoadipic acid, eight triacylglycerol species, and lowered sphingomyelin 42:2;2 levels are predictive of faster progression towards insulin requirement. Of ~1,300 proteins examined in two cohorts, levels of GDF15/MIC-1, IL-18Ra, CRELD1, NogoR, FAS, and ENPP7 are associated with faster progression, whilst SMAC/DIABLO, SPOCK1 and HEMK2 predict lower progression rates. In an external replication, proteins and lipids are associated with diabetes incidence and prevalence. NogoR/RTN4R injection improved glucose tolerance in high fat-fed male mice but impaired it in male db/db mice. High NogoR levels led to islet cell apoptosis, and IL-18R antagonised inflammatory IL-18 signalling towards nuclear factor kappa-B in vitro. This comprehensive, multi-disciplinary approach thus identifies biomarkers with potential prognostic utility, provides evidence for possible disease mechanisms, and identifies potential therapeutic avenues to slow diabetes progression.
  •  
160.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 151-160 av 193
Typ av publikation
tidskriftsartikel (172)
konferensbidrag (16)
annan publikation (1)
forskningsöversikt (1)
Typ av innehåll
refereegranskat (166)
övrigt vetenskapligt/konstnärligt (24)
Författare/redaktör
Aly, M (81)
Gronberg, H (56)
Brenner, H (54)
Gupta, R. (47)
Fischer, F (46)
Yonemoto, N (46)
visa fler...
Al-Aly, Z (45)
Farzadfar, F (44)
Malekzadeh, R (43)
Mohammed, S (42)
Eklund, M (42)
Shiri, R (40)
Jonas, JB (39)
Koyanagi, A (39)
Majeed, A (39)
Monasta, L (39)
Dandona, L (38)
Dandona, R (38)
Djalalinia, S (38)
Topor-Madry, R (38)
Rawaf, S (37)
Mendoza, W (36)
Naghavi, M (36)
Nangia, V (36)
Rahman, M (36)
Alvis-Guzman, N (35)
Negoi, I (35)
Radfar, A (35)
Werdecker, A (35)
Bikbov, B (34)
Hamidi, S (34)
Banach, M (33)
Bedi, N (33)
Hafezi-Nejad, N (33)
Khader, YS (33)
Panda-Jonas, S (33)
Tabares-Seisdedos, R (33)
Qorbani, M (33)
Kabir, Z (32)
Pana, A (32)
Kasaeian, A (32)
Basu, S (31)
Karch, A (31)
Khubchandani, J (31)
Kosen, S (31)
Mokdad, AH (31)
Remuzzi, G (31)
Sartorius, B (31)
Sepanlou, SG (31)
Vos, T (31)
visa färre...
Lärosäte
Karolinska Institutet (143)
Uppsala universitet (35)
Umeå universitet (23)
Göteborgs universitet (20)
Lunds universitet (18)
Chalmers tekniska högskola (7)
visa fler...
Högskolan Dalarna (6)
Södertörns högskola (5)
Luleå tekniska universitet (3)
Jönköping University (3)
Kungliga Tekniska Högskolan (2)
Örebro universitet (2)
Mittuniversitetet (2)
Stockholms universitet (1)
Högskolan i Gävle (1)
Linköpings universitet (1)
visa färre...
Språk
Engelska (193)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (98)
Samhällsvetenskap (11)
Naturvetenskap (2)
Teknik (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy